AAA 대법관은 모든 역지불 합의가 불법이라는 FTC의 주장을 받아들이기는 어렵다며 "FTC는 제약사 간 역지불 합의가 불법이라는 점을 입증해야 한다"고 덧붙였다.
Justice AAA stated that accepting the FTC's assertion that all reverse payment agreements are illegal is difficult, adding, "The FTC must prove that reverse payment agreements between pharmaceutical companies are illegal."